IBIO · iBio, Inc.
$1.47
+0.04 (+2.45%)
At close · Aug 17
Going-concern doubt
— cleared May 12, 2026
The latest filing states the doubt was alleviated.
“The history of significant losses, the negative cash flow from operations, and the dependence by the Company on its ability to obtain additional financing to fund its operations in the past raised substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$71.04M
Shares
49.68M
iBio, Inc. Earnings Call Transcripts
Every quarterly earnings call for iBio, Inc. (IBIO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲279.6%
$410,000
−$7.53M
'21 Q1
20-10-13
▲124.5%
$705,000
−$8.13M
'21 Q2
21-02-16
▲696.9%
$765,000
−$7.66M
'21 Q3
21-05-17
▼56.2%
$491,000
$116,000
'21 Q4
21-09-27
▼79.5%
$84,000
−$8.94M
'22 Q1
21-11-15
▼100%
$
−$11.92M
'22 Q2
22-02-14
▲135.3%
$1.80M
−$12.39M
'22 Q3
22-05-12
LATEST
▼100%
$
−$17.05M
'22 Q4
22-09-27
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY22 · Q4
2022-09-27
iBio, Inc. Q4 FY2022 Earnings Call
Revenue
$*
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-05-12
iBio, Inc. Q3 FY2022 Earnings Call
Revenue
$1.80M
▲ 135.3% YoY Diluted EPS
$-28.40
Gross margin
105.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-02-14
iBio, Inc. Q2 FY2022 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-27.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-11-15
iBio, Inc. Q1 FY2022 Earnings Call
Revenue
$84,000
▼ 79.5% YoY Diluted EPS
$-48.00
Gross margin
203.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-09-27
iBio, Inc. Q4 FY2021 Earnings Call
Revenue
$491,000*
▼ 56.2% YoY Gross margin
-32.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-05-17
iBio, Inc. Q3 FY2021 Earnings Call
Revenue
$765,000
▲ 696.9% YoY Diluted EPS
$-20.00
Gross margin
35.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-02-16
iBio, Inc. Q2 FY2021 Earnings Call
Revenue
$705,000
▲ 124.5% YoY Gross margin
70.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-10-13
iBio, Inc. Q1 FY2021 Earnings Call
Revenue
$410,000
▲ 279.6% YoY Gross margin
73.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–9 of 9 earnings calls
Key facts
CIK
1420720
CUSIP
451033708
13F (30d)
59 filings
56 filers
Visit website
Investor relations